Abstract:Objective center dot This study aims to investigate the main types of oculocutaneous albinism (OCA) and the distribution characteristics of mutations in the Chinese population. Additionally, genetic diagnosis and prenatal diagnosis were conducted for Chinese OCA families. Methods center dot A total of 116 blood DNA samples were collected from 40 unrelated families with suspected albinism. OCA gene testing and mutation screening were performed to identify mutated genes and genotypes. The prenatal genetic diagnosis was conducted on 20 fetal DNA samples (17 amniotic fluid DNA samples, 2 villus DNA samples, and 1 umbilical cord blood DNA sample). Follow-up was conducted on the born fetuses, and the feasibility and accuracy of prenatal genetic diagnosis were assessed based on the clinical phenotype of the fetuses. Results center dot Analysis of 40 pedigrees led to a molecular diagnosis for the patients or their parents: 24 (60%) had OCA1, 12 (30%) had OCA2, 1 (2.5%) had OCA3, and 2 (5%) had OCA4. Furthermore, 2.5% of the patients harbored only one heterozygous mutation in OCA2. The most common form of albinism observed was OCA1, followed by OCA2, OCA4, and OCA3. Prenatal diagnosis was performed on 20 fetuses, and the clinical phenotype of the fetuses aligned with the predictions of prenatal genetic diagnosis after follow-up. Conclusions center dot The results of gene mutation analysis in 40 families with oculocutaneous albinism indicate that OCA1 is the predominant type of albinism in the Chinese population, with all four types of OCA identified. Further research is needed to expand the understanding of pathogenic mutations associated with different types of OCA. Prenatal genetic testing, based on determining the albinism type and genotype of the proband and their parents, proves to be the most accurate and least traumatic method in eugenics. This study provides valuable insights into identifying novel therapeutic targets.

A New Method for Oculocutaneous Albinism Typing and Analysis of Two Novel Mutations in TYR Gene

Mutation Screening of the TYR and P Gene in Three Patients with Oculocutaneous Albinism

Mutational Analysis of the TYR and OCA2 Genes in Four Chinese Families with Oculocutaneous Albinism

Mutational Analysis of TYR, OCA2, and SLC45A2 Genes in Chinese Families with Oculocutaneous Albinism.

Identification of TYR Mutations in Patients with Oculocutaneous Albinism.

A Case of Ichthyosis Follicularis, Atrichia and Photophobia Syndrome Caused by a Novel Mutation in the MBTPS2 Gene

Identification and Characterization of Two Novel Noncoding Tyrosinase (TYR) Gene Variants Leading to Oculocutaneous Albinism Type 1.

Oculocutaneous Albinism Type 3 (OCA3): Analysis of Two Novel Mutations in TYRP1 Gene in Two Chinese Patients

Study of Tyrosinase Gene Mutation in Oculocutaneous Albinism Type 1 Patients

Genetic Analysis of 28 Chinese Families With Tyrosinase-Positive Oculocutaneous Albinism

Identification of 12 OCA Cases in Chinese Population and Two Novel Variants

Mutational Analysis of TYR, OCA2, SLC45A2, and TYRP1 Genes Identifies Novel and Reported Mutations in Chinese Families with Oculocutaneous Albinism.

[Prenatal Gene Diagnosis of Oculocutaneous Albinism Type I].

Identification of Genetic Mutations in TYR and OCA2 Genes in Congenital Families with Oculocutaneous Albinism (OCA)

Prenatal genetic diagnosis of oculocutaneous albinism type Ⅱ through mutation detection combined with SNPs linkage analysis

NGS-based targeted sequencing identified two novel variants in Southwestern Chinese families with oculocutaneous albinism

Genetic Analysis and Prenatal Diagnosis of 20 Chinese Families with Oculocutaneous Albinism.

Mutation Analysis of 63 Northwest Chinese Probands with Oculocutaneous Albinism

Identification of Five Novel Variants in Chinese Oculocutaneous Albinism by Targeted Next-Generation Sequencing

Identification of Novel Variations of Oculocutaneous Albinism Type 2 with Prader–Willi Syndrome/angelman Syndrome in Two Chinese Families

DNA Variations in Oculocutaneous Albinism: An Updated Mutation List and Current Outstanding Issues in Molecular Diagnostics